Subacute thyroiditis in psoriasis patients treated with biologics targeting tumor necrosis factor‐α and interleukin‐17A, a report of two cases

Subacute thyroiditis in psoriasis patients treated with biologics targeting tumor necrosis factor‐α and interleukin‐17A, a report of two cases

Bibliographic Details
Main Authors:	Kouki Nakamura, Masahiro Kamata, Shinichi Sato, Yoshihide Asano
Format:	Article
Language:	English
Published:	Wiley 2020-04-01
Series:	Journal of Cutaneous Immunology and Allergy
Online Access:	https://doi.org/10.1002/cia2.12093

Similar Items

Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
by: Keira A Fieldhouse, et al.
Published: (2020-04-01)

Interleukin-17A and Keratinocytes in Psoriasis
by: Masutaka Furue, et al.
Published: (2020-02-01)

Targeting of interleukin-17 in the treatment of psoriasis
by: Lønnberg AS, et al.
Published: (2014-09-01)

Association of genetic polymorphism of interleukin-17A & interleukin-17F with susceptibility of psoriasis
by: Rajinder Kaur, et al.
Published: (2018-01-01)

Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome
by: Magdalena Pirowska, et al.
Published: (2018-02-01)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
by: Tomasz Kaczyński, et al.
Published: (2019-09-01)

Increased Levels of Interleukin-17A Exosomes in Psoriasis
by: Claire Jacquin-Porretaz, et al.
Published: (2019-09-01)

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
by: Michael P. Schön, et al.
Published: (2018-06-01)

Effects of Interleukine-17A (Il-17A) and tumor necrosis factor alpha (TNF-α) on osteoblastic differentiation
by: Osta, Bilal
Published: (2014)

A case of subacute thyroiditis in a patient on adalimumab for treatment of refractory palmo-plantar psoriasis
by: Anca Chiriac, et al.
Published: (2014-01-01)

Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year
by: I Z Gaydukova, et al.
Published: (2017-04-01)

Interleukin-17 levels in patients with psoriasis with or without metabolic syndrome
by: Hanan Morsy, et al.
Published: (2019-01-01)

The Effects of Eight Weeks Swimming Training on Interleukin- 17, Interleukin- 18 and Tumor Necrosis Factor-α in Streptozotocin Induced Diabetic Rats
by: Mahboobe Karbalayi, et al.
Published: (2016-10-01)

Subacute Thyroiditis Evolving into Hashimoto Thyroiditis
by: Sumerah Jabeen, MBBS, FCPS (MED), et al.
Published: (2018-07-01)

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis
by: Céline Phan, et al.
Published: (2020-11-01)

Secukinumab – first in class interleukin-17A inhibitor for the treatment of psoriasis
by: Kiran Godse
Published: (2017-01-01)

Subacute Thyroiditis in a Child
by: Nordie A. Bilbao, MD, et al.
Published: (2019-05-01)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
by: Cauli A, et al.
Published: (2015-10-01)

Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
by: Luis E. Sánchez-Dueñas, MD, et al.
Published: (2020-07-01)

Eyelid Dermatitis as a Side Effect of Interleukin-17A Inhibitors in Psoriasis
by: Yuichi Teraki, et al.
Published: (2018-01-01)

Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
by: Makiko Yajima, et al.
Published: (2019-03-01)

Incidence of Toxoplasmosis in Psoriasis Patients and Possible Correlation with Tumor Necrosis Factor-α
by: Entsar J. Saheb, et al.
Published: (2020-03-01)

Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review
by: Masahiro Kamata, et al.
Published: (2020-03-01)

Refractory psoriasis vulgaris with itching successfully treated with the anti-interleukin-17A antibody secukinumab: A case of secondary failure of other biologic agents
by: Yuko Kurosaki, et al.
Published: (2017-01-01)

A Difficult Decision–Hashimoto’s Thyroiditis or Subacute Thyroiditis?
by: Süleyman İpekci, et al.
Published: (2011-12-01)

Drug-Induced Hypersensitivity Syndrome Followed by Subacute Thyroiditis
by: Mika Sato, et al.
Published: (2015-07-01)

Prognostic value of interleukin-10 and tumor necrosis factor-α polymorphisms in patients with hepatocellular carcinoma treated with transarterial chemoembolization
by: Ahmed A Ghafar, et al.
Published: (2019-01-01)

Subacute Thyroiditis Associated with COVID-19
by: Eugenia Campos-Barrera, et al.
Published: (2020-01-01)

Subacute Thyroiditis Revealing a Pheochromocytoma
by: Anna Furmaniuk, et al.
Published: (2016-01-01)

Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist
by: Qingran Li, et al.
Published: (2021-01-01)

Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases
by: Agnieszka Wasilewska, et al.
Published: (2016-08-01)

Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa
by: Marien Siqueira Soto Lopes, et al.
Published: (2013-11-01)

Increased levels of serum interleukin-17 in patients with Hashimoto's thyroiditis
by: Fatemeh Esfahanian, et al.
Published: (2017-01-01)

Synergistic Induction of Macrophage Inflammatory Protein-3α/CCL20 Production by Interleukin-17A and Tumor Necrosis Factor-αin Nasal Polyp Fibroblasts
by: Manabu Nonaka, MD, PhD, et al.
Published: (2009-01-01)

Salivary C-Reactive Protein in Hashimoto's Thyroiditis and Subacute Thyroiditis
by: Nivedita L. Rao, et al.
Published: (2010-01-01)

PERBANDINGAN EKSPRESI TUMOR NECROSIS FACTOR-α (TNF-α), INTERLEUKIN-1 (IL-1), DAN INTERLEUKIN-10 (IL-10) PADA LESI DAN NON-LESI PSORIASIS VULGARIS di RS. Dr. M. DJAMIL, PADANG
by: Sri Lestari, et al.
Published: (2009-05-01)

Efficacy of Biologics Targeting Tumour Necrosis Factor-alpha, Interleukin-17 -12/23, -23 and Small Molecules Targeting JAK and PDE4 in the Treatment of Nail Psoriasis: A Network Meta-analysis
by: Júlia Szebényi, et al.
Published: (2020-11-01)

Evaluation of interleukin-2 and tumor necrosis factor-α levels in patients with lichen
by: Mehmet Harman, et al.
Published: (2012-03-01)

Tumor Necrosis Factor-α and Interleukin-1- β Polymorphisms in Pre-Eclampsia
by: Zeinab Tavakkol Afshari, et al.
Published: (2016-12-01)

Polymorphism rs11465553 in the Interleukin-17F Gene in Serbian Patients with Psoriasis and Healthy Controls
by: Popadić Svetlana, et al.
Published: (2014-12-01)